Compass therapeutics reports fourth quarter and full year 2021 financial results and provides corporate update

Boston, march 21, 2022 (globe newswire) -- compass therapeutics, inc. (nasdaq: cmpx), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today reported fourth quarter and full year 2021 financial results and provided a corporate update.
CMPX Ratings Summary
CMPX Quant Ranking